Fortis Healthcare's Post

India continues to carry a significant burden of Sickle Cell Disease, particularly among certain tribal and underserved communities. Early diagnosis, genetic counselling, and timely intervention are key to improving outcomes and quality of life.

As highlighted by Dr. Vikas Dua, Principal Director & Head, Paediatric Haematology, Haemato-Oncology and Bone Marrow Transplant, Fortis Memorial Research Institute, Gurugram, greater awareness and early screening can help ensure timely care and better disease management.

At Fortis, we remain committed to advancing awareness and providing expert, multidisciplinary care for blood disorders.